Melanoma
-
Phase 3 Victory for Moderna and Merck’s mRNA Cancer Vaccine Signals Paradigm Shift in Personalized Oncology
Moderna and Merck’s mRNA cancer vaccine combined with Keytruda met Phase 3 goals in melanoma, driving stock surges and paving the way for FDA filing.
-
Advances in Melanoma Immunotherapy: Precision Medicine Meets Preventive Vigilance
New clinical data from the 2026 ASCO meeting highlights transformative gains in melanoma treatment via personalized vaccines and antibody therapies, even as global diagnosis rates hit record highs.
-
Finnian Garbutt Enters ‘Last Stages’ of Yearslong Cancer Battle
Actor Finnian Garbutt, 28, has announced he is entering the “last stages” of his yearslong melanoma battle after scans showed rapid progression. He appealed for support for his wife and young daughter.